Pengwei Ren

机构：Liaocheng University, Sichuan University, West China Hospital of Sichuan University · ORCID：0000-0001-9705-6470

发表论文 63 篇 · 总被引 1386 次 · h-index 20

代表论文

• The ROBINS‐I and the NOS had similar reliability but differed in applicability: A random sampling observational studies of systematic reviews/meta‐analysis (2021 · Journal of Evidence-Based Medicine · 被引 134)
• PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition (2022 · Journal of Experimental & Clinical Cancer Research · 被引 52)
• Persistent increase and improved survival of stage I lung cancer based on a large-scale real-world sample of 26,226 cases (2023 · Chinese Medical Journal · 被引 26)
• China Protocol for early screening, precise diagnosis, and individualized treatment of lung cancer (2025 · Signal Transduction and Targeted Therapy · 被引 24)
• The Relationship between Lymphocyte Subsets and the Prognosis and Genomic Features of Lung Cancer: A Retrospective Study (2021 · International Journal of Medical Sciences · 被引 21)
• Distinct clinicopathologic factors and prognosis based on the presence of ground-glass opacity components in patients with resected stage I non-small cell lung cancer (2020 · Annals of Translational Medicine · 被引 17)